7th Floor, Bandra-Kurla Complex, ...

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to ...

Узнайте о карьерных возможностях «Новартис» ниже. Дополнительные вакансии в разделе GTx Career Search. Навигация «Новартис» ...

Cerca posizioni aperte e/o invia una candidatura.

Senior Expert (Analytical R&D) - GC. Regular, Full time Innovative Medicines India Hyderabad (Office) fev 28, 2025 ...

Phase III data demonstrated clinically meaningful 35.1% proteinuria reduction 6; also, a stabilization of estimated glomerular filtration rate (eGFR) – a key measure of kidney function – was observed ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Job Title Sort ascending Business Location Site Date Posted External Animal Activities Manager/Senior Manager Regular, Full time Pharma Research USA +Alternative Locations Cambridge (USA) Mar 01, 2025 ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathway Abelacimab is currently in ...

Job Title Sort ascending Business Location Site Date Posted Sr. Product Specialist (Hematology) Regular (Sales), Full time Innovative Medicines Türkiye Adana Feb 18, 2025 Senior UI & UX ...

El presidente del Gobierno visita la planta de Novartis en La Almunia de Doña Godina (Zaragoza), uno de los cuatro centros de la compañía en el mundo para la producción de tratamientos oncológicos con ...

1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 47 of the Condensed Financial Report. Unless otherwise ...